e-learning
resources
Virtual 2020
Wednesday, 09.09.2020
Novelties in interventional pulmonology: expanding horizons
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Intratumoral Hyperthermic Chemotherapy Injection in Peripheral Non-Small Cell Lung Cancer; a Pilot Study.
M. Tohlob (Mansoura, Egypt), L. Suliman (Mansoura, Egypt), A. Elmorsy (Mansoura, Egypt), M. Ibrahim (Mansoura, Egypt), A. Hewidy (Mansoura, Egypt)
Source:
Virtual Congress 2020 – Novelties in interventional pulmonology: expanding horizons
Session:
Novelties in interventional pulmonology: expanding horizons
Session type:
Oral Presentation
Number:
5124
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Tohlob (Mansoura, Egypt), L. Suliman (Mansoura, Egypt), A. Elmorsy (Mansoura, Egypt), M. Ibrahim (Mansoura, Egypt), A. Hewidy (Mansoura, Egypt). Intratumoral Hyperthermic Chemotherapy Injection in Peripheral Non-Small Cell Lung Cancer; a Pilot Study.. 5124
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Emerging classes of drugs for the treatment of obstructive lung disease
Related content which might interest you:
Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Chaperone-Mediated Autophagy-Dependent Chemoresistance in Non-Small Cell Lung Cancer
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019
The Effect of Lipid Profile and Obesity on the Grade of Neutropenia in Patients with Small Cell Lung Cancer Treated with Etoposide-Cisplatin as First Regimen.
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
Resected Non-Small Cell Lung Cancer : A 5-year Experience
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Operations Which Are Technical and Difficult to Resolve in Non-Small Cell Lung Cancer: Videothoracoscopic Bi-lobectomies
Source: International Congress 2017 – General thoracic surgery
Year: 2017
Effects of Sustained and Intermittent Hypoxia on Human Lung Cancer Cells
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019
Performance of Super ARMS to Detect EGFR Mutation Status in Plasma Cell-free DNA in Advanced Non-Small Cell Lung Cancer Patients
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Use of Airway Epithelial Cell Cultures in Inflammatory Lung Disease Research
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
LSC - 2017 - Reprogramming Of Tumor Associated Macrophages By Modulating Wnt/ß-catenin Signalling In Lung Cancer.
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017
Short Term Multidisciplinary Pulmonary Rehabilitation Is Effective In Early Stage Non Small Cell Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
The Effect on Chest Tube Drainage of Postoperative Prophylactic Enoxaparin in Patients with Non-small Cell Lung Cancer
Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Year: 2018
Comparison of Exercise Capacity Respiratory Muscle Strength and Depression in Non-Small Cell Lung Cancer Patients and Healthy Controls
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020
Pretreatment Evaluation on Non-Small-cell Lung Cancer
Source: Guideline 1997
Year: 1997
Lung Microbiota and Streptococcal enrichment in Central Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Resistance Training Alone Improves Lung Inflammation and Respiratory Muscle Strenght but not Lung Function and Mechanics in Mid-Age Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade in Lung Cancer – A restrospective study.
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Prognostic Significance of Hematologic Biomarkers in Small Cell Lung Cancer: a Meta Analysis and Systematic Review
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Lung Micobiome in Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept